Stock Watch: Q3, Bonfire Of The Vaccine Manufacturers
Mixed Fortunes For Sanofi, Pfizer, Moderna And GSK
Pfizer’s and Moderna’s quarterly pandemic-related product sales could not mask other weaknesses while GSK’s quarter was marred by unimpressive non-pandemic vaccines sales.
